ARCHIVES

NCI Chips In $2 Million For AACR Meeting; Advisors, Senior Staff Not Consulted.

This article is from The Cancer Letter archive.

Vol. 29 No. | August 12, 2003

Download PDF Visit The Full Archive

Related Articles

Centocor Withdraws Yondelis After FDA Calls for New Study

April 29, 2011

Pesticides Not A Risk Factor For Long Island Breast Cancer, Study Finds

September 6, 2002

Gonzalez-Angulo Found Guilty in MD Anderson Poisoning Case

September 26, 2014

FDA Approves Erbitux for Head & Neck Cancer.

March 3, 2006

SPORE Eligibility, Cost Issues Clarified In Addendum To RFA

October 25, 1991

Cooperative Groups, NCI To Talk About Overlaps

March 14, 1975